390 related articles for article (PubMed ID: 24594197)
61. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
62. Protein arginine deiminase 4: evidence for a reverse protonation mechanism.
Knuckley B; Bhatia M; Thompson PR
Biochemistry; 2007 Jun; 46(22):6578-87. PubMed ID: 17497940
[TBL] [Abstract][Full Text] [Related]
63. Mining the Human Tissue Proteome for Protein Citrullination.
Lee CY; Wang D; Wilhelm M; Zolg DP; Schmidt T; Schnatbaum K; Reimer U; Pontén F; Uhlén M; Hahne H; Kuster B
Mol Cell Proteomics; 2018 Jul; 17(7):1378-1391. PubMed ID: 29610271
[TBL] [Abstract][Full Text] [Related]
64. Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution.
Shimizu A; Handa K; Honda T; Abe N; Kojima T; Takahara H
Comp Biochem Physiol B Biochem Mol Biol; 2014 Jan; 167():65-73. PubMed ID: 24161753
[TBL] [Abstract][Full Text] [Related]
65. Citrullination: a posttranslational modification in health and disease.
György B; Tóth E; Tarcsa E; Falus A; Buzás EI
Int J Biochem Cell Biol; 2006; 38(10):1662-77. PubMed ID: 16730216
[TBL] [Abstract][Full Text] [Related]
66. Expression of mouse uterine peptidylarginine deiminase in Escherichia coli: construction of expression plasmid and properties of the recombinant enzyme.
Ohsugi I; Takahara H; Shiraiwa M; Sugawara K
Arch Biochem Biophys; 1995 Feb; 317(1):62-8. PubMed ID: 7872804
[TBL] [Abstract][Full Text] [Related]
67. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
68. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?
Thompson PR; Fast W
ACS Chem Biol; 2006 Aug; 1(7):433-41. PubMed ID: 17168521
[TBL] [Abstract][Full Text] [Related]
69. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
[TBL] [Abstract][Full Text] [Related]
70. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
[TBL] [Abstract][Full Text] [Related]
71. Post-translational modifications such as citrullination are excellent targets for cancer therapy.
Brentville VA; Vankemmelbeke M; Metheringham RL; Durrant LG
Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199
[TBL] [Abstract][Full Text] [Related]
72. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996
[TBL] [Abstract][Full Text] [Related]
73. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.
Kilsgård O; Andersson P; Malmsten M; Nordin SL; Linge HM; Eliasson M; Sörenson E; Erjefält JS; Bylund J; Olin AI; Sørensen OE; Egesten A
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):240-8. PubMed ID: 21960546
[TBL] [Abstract][Full Text] [Related]
74. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
75. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin.
Kanno T; Kawada A; Yamanouchi J; Yosida-Noro C; Yoshiki A; Shiraiwa M; Kusakabe M; Manabe M; Tezuka T; Takahara H
J Invest Dermatol; 2000 Nov; 115(5):813-23. PubMed ID: 11069618
[TBL] [Abstract][Full Text] [Related]
76. Chemical biology of protein citrullination by the protein A arginine deiminases.
Mondal S; Thompson PR
Curr Opin Chem Biol; 2021 Aug; 63():19-27. PubMed ID: 33676233
[TBL] [Abstract][Full Text] [Related]
77. Importance of research on peptidylarginine deiminase and citrullinated proteins in age-related disease.
Ishigami A; Maruyama N
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S53-8. PubMed ID: 20590842
[TBL] [Abstract][Full Text] [Related]
78. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
[TBL] [Abstract][Full Text] [Related]
79. Effect of citrullination on the function and conformation of antithrombin.
Ordóñez A; Martínez-Martínez I; Corrales FJ; Miqueo C; Miñano A; Vicente V; Corral J
FEBS J; 2009 Nov; 276(22):6763-72. PubMed ID: 19843180
[TBL] [Abstract][Full Text] [Related]
80. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients.
Sharma M; Damgaard D; Senolt L; Svensson B; Bay-Jensen AC; Nielsen CH; Hägglund P
J Proteomics; 2019 Sep; 208():103484. PubMed ID: 31408709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
